Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids
Dear Editor, Systemic glucocorticoids remain a cornerstone of therapy in immunobullous diseases. Yet little is known about glucocorticoid induced osteoporosis (GIOP) in patients with immunobullous diseases. We performed a retrospective review of medical records at an immunodermatology clinic in a Si...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
PAGEPress Publications,
2024-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|